Northern Trust
SANA icon

Northern Trust’s Sana Biotechnology SANA Stock Holding History

Northern Trust’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
1,604,084
+125,233
+8% +$403K ﹤0.01% 2559
2026
Q1 		$4.26M Buy
1,478,851
+71,152
+5% +$280K ﹤0.01% 2544
2025
Q4 		$5.73M Buy
1,407,699
+89,203
+7% +$399K ﹤0.01% 2391
2025
Q3 		$4.68M Buy
1,318,496
+164,182
+14% +$594K ﹤0.01% 2539
2025
Q2 		$3.15M Sell
1,154,314
-145,009
-11% -$299K ﹤0.01% 2744
2025
Q1 		$2.18M Buy
1,299,323
+110,977
+9% +$310K ﹤0.01% 2881
2024
Q4 		$1.94M Buy
1,188,346
+60,004
+5% +$179K ﹤0.01% 3045
2024
Q3 		$4.69M Buy
1,128,342
+273,770
+32% +$1.44M ﹤0.01% 2509
2024
Q2 		$4.67M Sell
854,572
-11,569
-1% -$92.2K ﹤0.01% 2442
2024
Q1 		$8.66M Sell
866,141
-20,832
-2% -$156K ﹤0.01% 2129
2023
Q4 		$3.62M Buy
886,973
+54,366
+7% +$200K ﹤0.01% 2684
2023
Q3 		$3.22M Buy
832,607
+16,908
+2% +$90.9K ﹤0.01% 2680
2023
Q2 		$4.86M Buy
815,699
+53,299
+7% +$307K ﹤0.01% 2519
2023
Q1 		$2.49M Sell
762,400
-18,246
-2% -$72.9K ﹤0.01% 2845
2022
Q4 		$3.08M Sell
780,646
-9,869
-1% -$48.3K ﹤0.01% 2764
2022
Q3 		$4.74M Sell
790,515
-3,160
-0.4% -$22.8K ﹤0.01% 2522
2022
Q2 		$5.1M Buy
793,675
+35,379
+5% +$225K ﹤0.01% 2496
2022
Q1 		$6.26M Sell
758,296
-35,891
-5% -$290K ﹤0.01% 2450
2021
Q4 		$12.3M Buy
794,187
+8,069
+1% +$156K ﹤0.01% 2092
2021
Q3 		$17.7M Buy
786,118
+494,789
+170% +$10.4M ﹤0.01% 1886
2021
Q2 		$5.73M Buy
291,329
+127,148
+77% +$2.88M ﹤0.01% 2760
2021
Q1 		$5.5M Buy
+164,181
New +$5.35M ﹤0.01% 2688

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Northern Trust's SANA Position: Q2 2026 in Review

Northern Trust increased its Sana Biotechnology (SANA) stake by 8.5% in Q2 2026, buying an estimated $403K and bringing the position to 1,604,084 shares worth $5.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

Northern Trust first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $17.7M in Q3 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Northern Trust held 1,604,084 shares of Sana Biotechnology worth $5.6M as of Q2 2026.
  • Northern Trust bought 125,233 Sana Biotechnology shares in Q2 2026, an estimated $403K.
  • Sana Biotechnology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2559 holding.
  • Northern Trust first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Northern Trust's Sana Biotechnology position peaked at $17.7M in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.